Page last updated: 2024-09-04

vatalanib and ki23057

vatalanib has been researched along with ki23057 in 1 studies

Compound Research Comparison

Studies
(vatalanib)
Trials
(vatalanib)
Recent Studies (post-2010)
(vatalanib)
Studies
(ki23057)
Trials
(ki23057)
Recent Studies (post-2010) (ki23057)
2764298702

Protein Interaction Comparison

ProteinTaxonomyvatalanib (IC50)ki23057 (IC50)
Platelet-derived growth factor receptor betaHomo sapiens (human)0.2745
Mast/stem cell growth factor receptor KitHomo sapiens (human)0.0845
Platelet-derived growth factor receptor alphaHomo sapiens (human)0.48
Fibroblast growth factor receptor 2Homo sapiens (human)0.0785
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.076

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brullo, C; Musumeci, F; Radi, M; Schenone, S1

Other Studies

1 other study(ies) available for vatalanib and ki23057

ArticleYear
Vascular endothelial growth factor (VEGF) receptors: drugs and new inhibitors.
    Journal of medicinal chemistry, 2012, Dec-27, Volume: 55, Issue:24

    Topics: Angiogenesis Inhibitors; Animals; Clinical Trials as Topic; Humans; Models, Molecular; Neoplasms; Pyridines; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Structure-Activity Relationship

2012